Moderna, Vertex aiming for CFTR solution

Moderna Therapeutics Inc. (Cambridge, Mass.) and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) partnered to discover and develop mRNA

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE